Table 2.
Blood analysis and hemogram after treatment with placebo group (PG) or leucine group (LG).
| Variable | PG | LG | p value |
|---|---|---|---|
| Leukocytes (× 103/µL) | 7.5 ± 0.4 | 7.5 ± 0.6 | 0.97 |
| Neutrophils (× 103/µL) | 4.4 ± 0.2 | 4.5 ± 0.2 | 0.95 |
| Lymphocytes (× 103/µL) | 2.3 ± 0.1 | 2.2 ± 0.2 | 0.94 |
| Monocytes (× 103/µL) | 0.53 ± 0.03 | 0.54 ± 0.02 | 0.98 |
| Eosinophils (× 103/µL) | 0.22 ± 0.04 | 0.22 ± 0.05 | 1.00 |
| Basophils (× 103/µL) | 0.03 ± 0.01 | 0.03 ± 0.01 | 1.00 |
| Platelets (× 103/µL) | 240 ± 38 | 234 ± 32 | 0.82 |
| Erythrocytes (× 106/µL) | 5.0 ± 0.7 | 4.9 ± 0.4 | 0.86 |
| Hemoglobin (g/dL) | 12.3 ± 1.0 | 12.9 ± 1.2 | 0.97 |
| Glucose (mg/dL) | 97 ± 13 | 93 ± 12 | 0.88 |
| Urea (mg/dL) | 42 ± 5 | 44 ± 7 | 0.88 |
| GOT (U/L) | 28 ±4 | 27 ± 3 | 0.86 |
| GPT (U/L) | 23 ± 2 | 22 ± 4 | 0.94 |
| HDL cholesterol (mg/dL) | 44 ± 5 | 43 ± 7 | 0.96 |
| LDL cholesterol (mg/dL) | 122 ± 10 | 125 ± 14 | 0.71 |
| Triglycerides (mg/dL) | 127 ± 24 | 131 ± 18 | 0.70 |
| Total Proteins (g/dL) | 7.1 ± 0.3 | 7.2 ± 0.5 | 0.84 |
| Creatinine (mg/dL) | 0.81 ± 0.12 | 0.82 ± 0.13 | 0.91 |
| Calcium (mg/dL) | 8.5 ± 0.7 | 8.5 ± 0.8 | 1.00 |
| Sodium (mEq/L) | 140 ± 3 | 141 ± 4 | 0.91 |
| Potassium (mEq/L) | 4.5 ± 0.9 | 4.5 ± 0.7 | 0.96 |
| C-reactive Protein (mg/L) | 5.1 ± 1.8 | 5.6 ± 1.4 | 0.41 |
| TNF-α (pg/mL) | 2.8 ± 0.3 | 3.2 ± 0.5 | 0.42 |
| IL-6 (pg/mL) | 2.0 ± 0.3 | 2.4 ± 0.6 | 0.31 |
| Vit- D (25OHD) (ng/mL) | 40.1 ± 5.1 | 41.2 ± 5.2 | 0.92 |
GOT: glutamic oxaloacetic transaminase; GPT: Glutamic-pyruvate-transaminase; HDL: high-density lipoprotein; LDL: low-density lipoprotein.